Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1975 2
1976 1
1977 1
1978 1
1979 2
1980 3
1981 3
1983 2
1984 2
1985 1
1986 2
1987 1
1988 2
1989 1
1990 2
1991 16
1992 7
1993 7
1994 4
1995 5
1996 5
1997 6
1998 7
1999 2
2000 4
2001 5
2002 2
2003 4
2004 2
2005 1
2008 1
2011 1
2012 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

107 results

Results by year

Filters applied: . Clear all
Page 1
Experience with indium-111 and yttrium-90-labeled somatostatin analogs.
Virgolini I, Traub T, Novotny C, Leimer M, Füger B, Li SR, Patri P, Pangerl T, Angelberger P, Raderer M, Burggasser G, Andreae F, Kurtaran A, Dudczak R. Virgolini I, et al. Among authors: angelberger p. Curr Pharm Des. 2002;8(20):1781-807. doi: 10.2174/1381612023393756. Curr Pharm Des. 2002. PMID: 12171531 Review.
New trends in peptide receptor radioligands.
Virgolini I, Traub T, Novotny C, Leimer M, Füger B, Li SR, Patri P, Pangerl T, Angelberger P, Raderer M, Andreae F, Kurtaran A, Dudczak R. Virgolini I, et al. Among authors: angelberger p. Q J Nucl Med. 2001 Jun;45(2):153-9. Q J Nucl Med. 2001. PMID: 11476164 Review.
Evaluation of somatostatin receptors in human cancer.
Pantev T, Virgolini I, Neuhold N, Angelberger P, Luger A, Sinzinger H. Pantev T, et al. Among authors: angelberger p. Wien Klin Wochenschr. 1991;103(21):649-53. Wien Klin Wochenschr. 1991. PMID: 1663300
Vasoactive intestinal peptide receptor scintigraphy.
Virgolini I, Kurtaran A, Raderer M, Leimer M, Angelberger P, Havlik E, Li S, Scheithauer W, Niederle B, Valent P, et al. Virgolini I, et al. Among authors: angelberger p. J Nucl Med. 1995 Oct;36(10):1732-9. J Nucl Med. 1995. PMID: 7562036 Free article.
New radiopharmaceuticals for receptor scintigraphy and radionuclide therapy.
Virgolini I, Traub T, Leimer M, Novotny C, Pangerl T, Ofluoglu S, Halvadjieva E, Smith-Jones P, Flores J, Li SR, Angelberger P, Havlik E, Andreae F, Raderer M, Kurtaran A, Niederle B, Dudczak R. Virgolini I, et al. Among authors: angelberger p. Q J Nucl Med. 2000 Mar;44(1):50-8. Q J Nucl Med. 2000. PMID: 10932601 Review.
Imaging of advanced neuroendocrine tumors with (18)F-FDOPA PET.
Becherer A, Szabó M, Karanikas G, Wunderbaldinger P, Angelberger P, Raderer M, Kurtaran A, Dudczak R, Kletter K. Becherer A, et al. Among authors: angelberger p. J Nucl Med. 2004 Jul;45(7):1161-7. J Nucl Med. 2004. PMID: 15235062 Free article. Clinical Trial.
[123I]beta-CIT and SPECT in essential tremor and Parkinson's disease.
Asenbaum S, Pirker W, Angelberger P, Bencsits G, Pruckmayer M, Brücke T. Asenbaum S, et al. Among authors: angelberger p. J Neural Transm (Vienna). 1998;105(10-12):1213-28. doi: 10.1007/s007020050124. J Neural Transm (Vienna). 1998. PMID: 9928890
107 results